RETURN OF FERTILITY AFTER DISCONTINUATION OF DEPOT MEDROXYPROGESTERONE ACETATE AND INTRA-UTERINE DEVICES IN NORTHERN THAILAND
References (11)
- et al.
Depo-medroxyprogesterone acetate as a contraceptive agent: return of fertility after discontinuation of use
Contraception
(1973) - et al.
The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review
Contraception
(1974) Fertility after removal of the intrauterine ring
Fert Steril
(1970)- et al.
Acceptance and use of Depo-Provera in Chiang Mai
IPPF Med Bull
(1975) Advances in Methods of Fertility Regulation. Report of a WHO Scientific Group
WHO Tech Rep Ser
(1975)
Cited by (56)
Intrauterine device use, sexually transmitted infections, and fertility: a prospective cohort study
2021, American Journal of Obstetrics and GynecologyCitation Excerpt :The FACT Study participants met the following inclusion criteria: (1) ages 18 to 35 years, (2) desiring conception, (3) sexually active with a male partner, (4) ability to consent in English or Spanish, and (5) willing to comply with all study procedures and follow-up. We excluded patients with a positive pregnancy test at baseline, if they had a history of infertility or were surgically sterile, and if they used DMPA in the past 5 months, as DMPA can be associated with a longer return to fertility.8 Before enrollment, we obtained institutional review board approval, and all participants completed the informed consent process.
Progestin-only contraception: Injectables and implants
2014, Best Practice and Research: Clinical Obstetrics and GynaecologyCitation Excerpt :WHO advises that repeat injections can be given 2 weeks early or up to 2 weeks late for NET-EN and 2 weeks early or up to 4 weeks late for DMPA [25,30]. Return to fertility after a DMPA-IM injection averages between 9 and 10 months (i.e. 6–7 months longer than the expected duration of effect; one study reported a range of 4–31 months) [31,32]. This may be slightly shorter with NET-EN [33].
Gestational trophoblastic disease
2012, Best Practice and Research: Clinical Obstetrics and GynaecologyCitation Excerpt :Longer time may be needed for return of fertility after the use of depot medroxyprogesterone (DMPA), which takes about 4–5 months for the return of ovulation and about 5–7 months for conception, although the ovulation suppression may rarely persist for as long as 18 months after the last injection.84,96 A Thai study,97 which included 796 women using DMPA, showed a median delay of 5.5 months before conception. As the effect of DMPA can last for 15 weeks, a median delay to conception of around 9 months after the last injection can be anticipated.
Egon R. Diczfalusy, the discovery of the fetoplacental unit and much more
2011, ContraceptionReturn to fertility after cessation of a continuous oral contraceptive
2009, Fertility and SterilityReturn to fertility following discontinuation of oral contraceptives
2009, Fertility and SterilityCitation Excerpt :Of the progestin-only contraceptives, only the progestin-only pill has been shown to have conception rates comparable to that of combined OCs or nonhormonal family planning methods. Specifically, the 12-month conception rate in women discontinuing progestin-only pills in order to conceive is 95% (1), compared with 70%–78% in women discontinuing depot medroxyprogestrone acetate (DMPA) injections (26, 27) and 77%–81% in women discontinuing Norplant (levonorgestrel implants: Wyeth, Collegeville, PA) (27, 48). As noted, the rates seen with progestin-only pills are comparable to 12-month conception rates in women wishing to conceive after discontinuing the use of condoms (91%) (1), or natural family planning by timing of intercourse (n = 342), showing that 92% had conceived by 12 months (49).
- 1
Present address: Department of Medical Statistics and Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street (Gower Street), London WC1E 7HT.